Cynata Therapeutics (ASX:CYP): Interview with CEO Dr. Ross Macdonald

October 14, 2021

Cynata Therapeutics, CYP


We talked with Cynata Therapeutics CEO Dr. Ross Macdonald about the multiple clinical-stage opportunities the Cymerus technology has created, including its potential use in COVID-19 where a trial is now underway.


Read our most recent article on CYP here